POMGNT1 (c.1539+1G>A,) is characterized by congenital muscular dystrophy, ocular abnormalities including: severe congenital myopia, congenital glaucoma, pallor of the optic disks, retinal hypoplasia and intellectual disability, hydrocephalus and generalized muscle weakness.